Journal of Neurovirology

Papers
(The median citation count of Journal of Neurovirology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report62
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review33
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection24
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab22
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response21
Correction: The presence of human polyomavirus JC (JCPyV) in pediatric brain tumors: a plausible trigger in Wnt/β-catenin pathway21
Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking19
HIV associated motor neuron disease (MND): A case series with systematic review of literature19
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report19
Progressive multifocal leukoencephalopathy in a young adult with DOCK8 deficiency: a case of JC virus reactivation in primary immunodeficiency19
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats17
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report14
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma14
Serum but not cerebrospinal fluid biomarkers are associated with domain-specific cognitive performance in PWH13
Time since HIV diagnosis is linked to amnestic mild cognitive impairment (MCI) in older adults with HIV13
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation13
MicroRNA biomarkers for JC virus reactivation and progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients: a systematic review12
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody11
Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia10
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV10
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study10
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis10
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis9
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases9
HIV-associated multiple intracranial aneurysms and stroke in an adult patient: successful treatment with a combination of glucocorticoid and antiviral agents8
Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients8
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice8
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study8
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma8
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers8
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson’s disease8
In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus8
Journal of neurovirology8
Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid8
Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals8
Differential effects of fentanyl compared to morphine on neuroinflammatory signaling in the brain in EcoHIV-infected mice7
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis7
Correction to: Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system7
Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV7
Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes7
Comment on “Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection”6
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV6
Cognitive deficits in HTLV-1 patients6
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature6
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country6
Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy6
Retraction Note: The anticancer drug sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration6
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report6
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma5
Implications of vascular depression for successful cognitive aging in HIV Disease5
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature5
Unmasking HAM/TSP: understanding HTLV-1-driven neurological disease5
Metformin promotes PEN2 expression to attenuate microglia-mediated neurotoxicity induced by HIV-1 Tat5
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications5
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells5
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau5
Maintaining the battle against vaccine-preventable neurological diseases in the United States5
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use5
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV4
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation4
Beyond accuracy: facial emotion perception bias in people with HIV in Uganda4
Encephalomyelitis in a patient with monkeypox: an unusual complication4
Monkeypox virus replication underlying circadian rhythm networks4
Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV4
Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV4
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations4
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex4
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study4
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes4
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology4
Comparison of clinical, radiological and outcome parameters in patients with progressive multifocal leukoencephalopathy (PML) with and without HIV infection: a cohort study4
Clinical features of varicella-zoster virus meningitis diagnosed by polymerase chain reaction without abnormal routine cerebrospinal fluid analysis4
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation4
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis4
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”4
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder4
A viral attack on brain tumors: the potential of oncolytic virus therapy4
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”3
Proteomic and machine learning signatures of rabies virus infection reveal stage-specific biomarkers3
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) stu3
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants3
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells3
Amebic infections of the central nervous system3
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV3
Correction: Varicella zoster virus meningoencephalitis and vasculopathy in an immunocompromised patient with rheumatoid arthritis: a diagnostic challenge3
Central nervous system reactivation of herpesviridae family in patients with COVID-193
Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?3
Reactivation of varicella zoster virus following trigeminal schwannoma resection3
Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches3
High glucose potentiates Zika virus induced-astroglial dysfunctions3
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases3
The dual role of ACE2 in viral infections and neurodegeneration: mechanisms and therapeutic opportunities3
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate3
A report of progressive multifocal leukoencephalopathy during adjuvant abemaciclib for breast cancer3
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV3
Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV3
CSF CXCL13 as a longitudinal marker for neurocognition in HIV-1-associated dementia after start of treatment in cART-naïve patients3
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro3
Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India3
The synergistic effect of insomnia and depression on risk of herpes zoster3
Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors: a case report3
A cross-cohort comparison of the prevalence and clinical significance of Alzheimer’s disease biomarkers in people with versus without HIV2
Bell’s palsy as the initial manifestation of Listeria monocytogenes rhombencephalitis with brainstem abscesses in an immunocompetent adult: a case report2
The presence of human polyomavirus JC (JCPyV) in pediatric brain tumors: a plausible trigger in Wnt/β-catenin pathway2
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections2
Norovirus-associated neurological manifestations: summarizing the evidence2
Induced expression of rabies glycoprotein in the dorsal hippocampus enhances hippocampal dependent memory in a rat model of Alzheimer’s disease2
Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature2
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo2
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice2
Combination antiretroviral therapy prevents SIV-induced aging in the hippocampus and neurodegeneration throughout the brain2
A frantic confusion: beyond rabies and anti-N-methyl-D-aspartate encephalitis2
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons2
Assessing cognitive impairment in HIV-infected: a comparative study of international HIV Dementia Scale, HIV Dementia Scale Italian version and Montreal cognitive assessment in clinical practice2
Rapid decline of cerebrospinal fluid biomarkers of axonal injury and neuroinflammation after initiation of antiretroviral therapy in HIV2
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder2
Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis2
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins2
Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents2
Cognitive dysfunction following COVID-19 infection2
Chronic granulomatosis with persistent HSV intrathecal synthesis over three years: a rare complication of HSV encephalitis in adult2
Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment2
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV2
Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B2
Additive cortical gray matter deficits in people living with HIV who use cocaine2
Multi-functional auto-fluorescent nanogels for theranostics2
Regulation of eco-tropic human immunodeficiency virus type-1-infection by sterile alpha motif and histidine-aspartic domain containing protein-1 in a microglial cell line: a novel in vitro model for s2
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial2
HIV viremia contributes to neurocognitive impairments in persons who use cocaine2
Role of extracellular vesicles derived from HIV-infected T cells and microglial cells in neuroinflammation and neuropathogenesis using a blood–brain barrier and cerebral organoid co-culture model2
RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection2
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD42
Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital2
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran2
0.083671092987061